Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Daptomycin as Adjunctive Therapy for Staphylococcus Aureus Bacteremia

NCT02972983 is registered in ClinicalTrials.gov with McGill University Health Centre/Research Institute of the McGill University Health Centre as lead sponsor.

NCT NCT02972983
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02972983 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Daptomycin as Adjunctive Therapy for Staphylococcus Aureus Bacteremia
Lead sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase
Phase 4
Overall status
Completed
Start date
December 1, 2016
Completion date
September 30, 2019
Enrollment
102 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bacteremia, methicillin susceptible staphylococcus aureus septicemia